Cargando…

Long term stability of paraoxonase-1 and high-density lipoprotein in human serum

BACKGROUND: Paraoxonase-1 (PON1) is an enzyme with numerous functions and receives an increasing interest in clinical and epidemiological studies. Sometimes samples are stored for longer periods at a certain temperature. Therefore the stability of PON1 activity must be checked and retained upon stor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beekhof, Piet K, Gorshunska, Maryana, Jansen, Eugène HJM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430585/ https://www.ncbi.nlm.nih.gov/pubmed/22584062 http://dx.doi.org/10.1186/1476-511X-11-53

Ejemplares similares

Stability of Folate and Vitamin B(12) in Human Serum after Long-Term Storage: A Follow-Up after 13 Years
por: Jansen, Eugène H. J. M., et al.
Publicado: (2018)

Serum Paraoxonase 1 Activity Is Associated with Fatty Acid Composition of High Density Lipoprotein
por: Boshtam, Maryam, et al.
Publicado: (2013)

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity
por: Razavi, Amirnader Emami, et al.
Publicado: (2012)

Functionally Defective High-Density Lipoprotein and Paraoxonase: A Couple for Endothelial Dysfunction in Atherosclerosis
por: Eren, Esin, et al.
Publicado: (2013)

Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010)

Dietary Squalene Increases High Density Lipoprotein-Cholesterol and Paraoxonase 1 and Decreases Oxidative Stress in Mice
por: Gabás-Rivera, Clara, et al.
Publicado: (2014)

Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
por: Mastorikou, M, et al.
Publicado: (2008)

Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2019)

Comparative Analysis of Serum (Anti)oxidative Status Parameters in Healthy Persons
por: Jansen, Eugène HJM, et al.
Publicado: (2013)

Evaluation of Paraoxonase, Malondialdehyde, and Lipoprotein Levels in Patients with Asymptomatic Cholelithiasis
por: Atamer, Aytac, et al.
Publicado: (2014)

Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome
por: Furuyama, Fumiaki, et al.
Publicado: (2018)

Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice
por: Zhao, Xiao-Jie, et al.
Publicado: (2021)

Impact of the 24-h ultramarathon race on homocysteine, oxidized low-density lipoprotein, and paraoxonase 1 levels in professional runners
por: Benedetti, Serena, et al.
Publicado: (2018)

Tissue-Specific Effects of Vitamin E Supplementation
por: Jansen, Eugene, et al.
Publicado: (2016)

Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2019)

High-Density Lipoproteins and Serum Amyloid A (SAA)
por: Webb, Nancy R.
Publicado: (2021)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Associations of Human Colorectal Adenoma with Serum Biomarkers of Body Iron Stores, Inflammation and Antioxidant Protein Thiols
por: Schöttker, Ben, et al.
Publicado: (2021)

The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
por: Moshtaghie, Elham, et al.
Publicado: (2022)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Effects of smoking cessation using varenicline on the serum concentrations of oxidized high-density lipoprotein: Comparison with high-density lipoprotein cholesterol
por: Umeda, Akira, et al.
Publicado: (2022)

Effect of Lycopene Application in Rats with Experimental Diabetes Using Lipoprotein, Paraoxonase and Cytokines
por: Yegin, Sevim Çiftçi, et al.
Publicado: (2013)

Serum high-density lipoprotein level and prognosis of ovarian cancer
por: Hongyan, Jiang, et al.
Publicado: (2023)

Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
por: Agilli, Mehmet, et al.
Publicado: (2014)

Serum Paraoxonase as an Indicator for Fatty Liver in Sheep
por: Cao, Yu, et al.
Publicado: (2017)

Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013)

Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention
por: Fukase, Tatsuya, et al.
Publicado: (2023)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

The clinical significance of preoperative serum triglyceride, high-density lipoprotein, and low-density lipoprotein levels in lung squamous cell carcinoma
por: Li, Zhupeng, et al.
Publicado: (2022)

Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1
por: Blaha-Nelson, David, et al.
Publicado: (2016)

Human paraoxonase 2
por: Porntadavity, Sureerut, et al.
Publicado: (2010)

High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease
por: Jayakumari, Narayani, et al.
Publicado: (2009)

The Long and Winding Road: To the Proper Understanding of High-density Lipoprotein
por: Sung, Jidong
Publicado: (2020)

Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014)

Response to: Serum Paraoxonase and Malondialdehyde Levels in Asymptomatic Cholelithiasis
por: Atamer, Aytaç, et al.
Publicado: (2016)

Difference in Serum Non-High-Density Lipoprotein Cholesterol Levels in terms of Sex, Age, and Physique in Children and Adolescents
por: Abe, Yuriko
Publicado: (2016)

Serum paraoxonase (a high-density lipoprotein-associated lipophilic antioxidant) activity in clinical follow-up of patients with acute pancreatitis, with particular emphasis on oxidative stress parameters and lipid profile: a prospective pilot trial
por: Yuksekdag, Sema, et al.
Publicado: (2019)

Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic Wistar rats
por: Babashahi, Mina, et al.
Publicado: (2015)

Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice
por: Charles-Schoeman, Christina, et al.
Publicado: (2020)

High-Density Lipoproteins and the Kidney
por: Strazzella, Arianna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5568sqv3koqirb3lalua3cvhgf